Pancreatic Cancer and Detection Methods
- PMID: 37760999
- PMCID: PMC10526344
- DOI: 10.3390/biomedicines11092557
Pancreatic Cancer and Detection Methods
Abstract
The pancreas is a vital organ with exocrine and endocrine functions. Pancreatitis is an inflammation of the pancreas caused by alcohol consumption and gallstones. This condition can heighten the risk of pancreatic cancer (PC), a challenging disease with a high mortality rate. Genetic and epigenetic factors contribute significantly to PC development, along with other risk factors. Early detection is crucial for improving PC outcomes. Diagnostic methods, including imagining modalities and tissue biopsy, aid in the detection and analysis of PC. In contrast, liquid biopsy (LB) shows promise in early tumor detection by assessing biomarkers in bodily fluids. Understanding the function of the pancreas, associated diseases, risk factors, and available diagnostic methods is essential for effective management and early PC detection. The current clinical examination of PC is challenging due to its asymptomatic early stages and limitations of highly precise diagnostics. Screening is recommended for high-risk populations and individuals with potential benign tumors. Among various PC screening methods, the N-NOSE plus pancreas test stands out with its high AUC of 0.865. Compared to other commercial products, the N-NOSE plus pancreas test offers a cost-effective solution for early detection. However, additional diagnostic tests are required for confirmation. Further research, validation, and the development of non-invasive screening methods and standardized scoring systems are crucial to enhance PC detection and improve patient outcomes. This review outlines the context of pancreatic cancer and the challenges for early detection.
Keywords: C. elegans; N-NOSE; detection methods; early-cancer screening; pancreatic cancer.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
DEPEND study protocol: early detection of patients with pancreatic cancer - a pilot study to evaluate the utility of faecal elastase-1 and 13C-mixed triglyceride breath test as screening tools in high-risk individuals.BMJ Open. 2022 Feb 25;12(2):e057271. doi: 10.1136/bmjopen-2021-057271. BMJ Open. 2022. PMID: 35217541 Free PMC article.
-
Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.World J Gastroenterol. 2020 Apr 14;26(14):1660-1673. doi: 10.3748/wjg.v26.i14.1660. World J Gastroenterol. 2020. PMID: 32327914 Free PMC article.
-
Extracellular Vesicles as Potential Biomarkers for Early Detection and Diagnosis of Pancreatic Cancer.Biomedicines. 2020 Dec 7;8(12):581. doi: 10.3390/biomedicines8120581. Biomedicines. 2020. PMID: 33297544 Free PMC article. Review.
-
Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk Individuals.Gastroenterology. 2022 Mar;162(3):772-785.e4. doi: 10.1053/j.gastro.2021.10.014. Epub 2021 Oct 19. Gastroenterology. 2022. PMID: 34678218
-
Early detection of pancreatic cancer: Where are we now and where are we going?Int J Cancer. 2017 Jul 15;141(2):231-241. doi: 10.1002/ijc.30670. Epub 2017 Mar 19. Int J Cancer. 2017. PMID: 28240774 Review.
Cited by
-
Pigment Epithelial-Derived Factor in Pancreatic and Liver Cancers-From Inflammation to Cancer.Biomedicines. 2024 Oct 4;12(10):2260. doi: 10.3390/biomedicines12102260. Biomedicines. 2024. PMID: 39457573 Free PMC article. Review.
References
-
- Pandol S. The Exocrine Pancreas. Morgan & Claypool Publishers; San Rafael, CA, USA: 2011. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources